为哌拉西林和β内酰胺酶的不可逆抑制剂他唑巴坦按8:1的比例组成,他唑巴坦为舒巴坦的衍生物,但其抑制作用优于舒巴坦,本品对耐哌拉西林的大肠埃希菌、肺炎克雷伯菌、奇异变形杆菌、不动杆菌等有良好的抗菌作用。用于敏感菌引起的败血症、腹腔感染、呼吸道感染和软组织感染,亦可用于颅内感染。
目的比较哌拉西林他唑巴坦与头孢曲松治疗下呼吸道感染的疗效和费用。
Aim To compare the efficacy and cost of piperacillin-tazobactam vs ceftriaxone in treating moderate severe pneumonia.
本文系统研究了复方抗生素制剂哌拉西林钠他唑巴坦钠制备时的混粉工艺及质量标准。
Objective to study the mixing process and quality standard of antibiotic compound preparation piperacillin sodium and tazobactam sodium.
方法回顾性分析哌拉西林-他唑巴坦联合左氧氟沙星治疗55例SCAP的临床疗效。
Methods The clinical efficacy data of 55 SCAP patients treated with piperacillin-tazobactam combined with levofloxacin were retrospectively analyzed.
应用推荐